Search PubMed⌕ Search

Biomedical subjects

H Zhuang

Publications and source records attributed to H Zhuang.

At least 91 records · Page 5Linked to original sources

[Studies on GBV-C infection in blood donors in four provinces of China].

Plasma antibody against GBV-C (anti-GBV-C) and GBV-C RNA were detected with enzyme immunoassay (EIA) and reverse transcription nested polymerase chain reaction (RT-nPCR) in blood donors to study the prevalence of GBV-C infection in blood donors. Positivity of anti-GBV-C was 4.92 percent in 1,200 plasma donors (59/1,200), and that of GBV-C RNA was 64.41 percent in those with positive anti-GBV-C (38/59). Positivity of anti-GBV-C was 2.86 percent in 350 whole blood donors (10/350) and that of GBV-C RNA was 60.00 percent in those with positive anti-GBV-C (6/10). Positive rate of anti-GBV-C in those who donated blood for more than 10 years was higher than in control group. It suggests that infection with GBV-C was more often in plasma and blood donors. There were blood donors with positive GBV-C RNA but normal ALT activities and those both positive in GBV-C RNA and HCV RNA. It is urgent to detect the markers of GBV-C infection in blood donors as soon as possible.

Adolescent↗

[A study on viremia in patients with hepatitis E].

Hepatitis E virus RNA (HEV RNA) was detected in 531 serial serum specimens collected from 62 hospitalized patients with hepatitis E by reverse transcription-nested polymerase chain reaction (RT-nPCR) setting two pairs of primer from open reading frame 1 (ORF1) to understand the process of HEV infection more thoroughly. Results showed that 71 percent of the patients were positive for HEV RNA. Thirty-two of them with 288 serial serum specimens were followed up for the whole process, and 24 cases (75%) were positive for HEV RNA, positive rates declined with the course of the disease and serum HEV RNA lasted for 20.6 days in average. Serum HEV RNA was kept positive in 36 of the 44 patients (81.8%) at the time their serum alanine aminotransferase (ALT) and serum total bilirubin began to lower, and anti-HEV was detected in 39 of them (88.6%). Proportion of HEV viremia and length of it had no direct relationship with serum ALT and levels of total serum bilirubin and anti-HEV.

Hepatitis E↗

[Musical relaxation therapy on the cerebral arteriosclerosis].

The transcranial Doppler and psychological measurement methods were used to evaluate the effect of musical relaxation therapy on the cerebral arteriosclerosis. The results showed that the musical relaxation therapy could improve the cerebral blood flow (physiological), offset the Type A behavior and eliminate the emotional disturbance (psychological), and that its effect was better than that of the control patients. The mechanism of the effect may be related to the 1/f sound wave (physical), abdominal respiration with long expiration and involuntary inspiration (physiological) and the hinting effects of the inducing phrases (psychological).

Aged↗

[The changes of PRA, ATII, ald, ET and ANP in patients with left ventricular diastolic heart failure and intervention with enalapril].

Fifty patients with left ventricular diastolic heart failure (LVDHF), and 35 patients with left ventricular systolic heart failure (LVSHF) diagnosed by clinical manifestation and radionuclide ventriculography were studied and 20 normal persons served as controls. Plasma renin activity (PRA), angiotensin I (AT I), aldosterone (ALD), endothelin (ET) and atrial natriuretic peptide (ANP) concentrations were measured by radioimmunoassay. Fifty patients with LVDHF were divided into treatment group and control group in a randomized, double blind, control method. Enalpril, CoQ10 and VitE were given in treatment group while only CoQ10 and VitE were given in control group. The therapeutic efficacy was evaluated after 8 weeks of treatment. The results showed that plasma concentration of PRA, AT I, ALD, ET and ANP were increased in LVDHF, but lower than those in LVSHF. After treatment with enalapril plasma PRA was increased while AT I, ALD and ET level were decreased significantly but ANP level had no change in treatment group.

Adult↗

Mechanical strain-induced proliferation of osteoblastic cells parallels increased TGF-beta 1 mRNA.

It is well known that mechanical stimulation can prompt healing of bone fractures. However, the mechanism involved is less clear. In this study, we found that a 0.17% cyclic, biaxial mechanical strain delivered at 1 Hz increased proliferation of MC3T3-E1 cells, a clonal osteoblastic cell line. Mechanical strain also increased the level of TGF-beta 1 mRNA determined by quantitative reverse transcription/ polymerase chain reaction. Previous reports have shown that neomycin and W-7, which are inhibitors in the inositol phosphate/calmodulin pathway, blocked mechanical strain-induced proliferation of the osteoblast cells. Interestingly, we found that neomycin and W-7 can also block mechanical stimulation-induced elevation of TGF-beta 1 mRNA. Finally, using an antibody which blocked the action of TGF-beta 1, we found that the increased MC3T3-E1 cell proliferation induced by mechanical strain did not depend on the action of TGF-beta 1.

3T3 Cells↗

The impact of alteration of polyunsaturated fatty acid levels on C6-aldehyde formation of Arabidopsis thaliana leaves.

C6-aldehydes are synthesized via lipoxygenase/hydroperoxide lyase action on polyunsaturated fatty acid (PUFA) substrates in plant leaves. The source pools and subcellular location of the processes are unknown. A close relationship is found between the composition of PUFA and the composition of C6-aldehydes. In the current study, this relationship was tested using the Arabidopsis PUFA mutant lines act1, fad2, fad3, fad5, fad6, and fad7. The results indicate that C6-aldehyde formation is influenced by the alteration of C18 PUFA levels. Mutants act1 and fad5, which are deficient in C16 unsaturated fatty acids, had wild-type levels of C6-aldehyde production. Mutants deficient in the chloroplast hexadecenoic acid/oleic acid desaturase (fad6) or hexadecadienoic acid/linoleic acid desaturase (fad7) had altered C6-aldehyde formation in a pattern similar to the changes in the PUFA. Mutations that impair phosphatidylcholine desaturase activity, such as fad2 and fad3, however, resulted in increased E-2-hexenal formation. The enzymes involved in C6-aldehyde production were partially characterized, including measurement of pH optima. The differences in C6-aldehyde formation among the fatty acid mutants of Arabidopsis appeared not to result from alteration of lipoxygenase/hydroperoxide lyase pathway enzymes. Investigation of the fatty acid composition in leaf phospholipids, glycolipids, and neutral lipids and analysis of the fatty acid composition of chloroplast and extrachloroplast lipids indicate that chloroplasts and glycolipids of chloroplasts may be the source or major source of C6-aldehyde formation in Arabidopsis leaves.

Aldehydes↗

Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.

PRL regulates milk gene expression, at least in part, by activating JAK2 kinase and STAT5 (signal transducer and activator of transcription 5), initially termed mammary gland factor (MGF). These experiments were initiated to gain a better understanding of the mechanisms of transcriptional activation via PRL receptor (PRL-R) signaling. Binding of PRL to the recombinant pigeon PRL-R-activated transcription driven by a 2.8 kbp 5'-fragment of the rat beta-casein gene. PRL enhanced the expression of chimeric reporters containing the beta-casein PRL response element (PRE), but not the c-fos sis-inducible element, when the reporters were transfected into Chinese hamster ovary cells with the PRL-R. Wild type receptor, which contains a duplication of the entire extracellular ligand-binding domain, was only slightly more effective than a truncation mutant with a single extracellular domain. Transfection with either JAK1, JAK2, or JAK3 increased basal transcription through both the PRE and sis-inducible element. Coexpression of JAK2 with PRL-R resulted in amplification of the induction of the PRE by PRL, whereas JAKs 1 and 3 did not amplify the PRL effect. Overexpression of JAK2 mutants blocked PRE activation by PRL. Mutant JAK2 also interfered with PRE activation by JAK3 but did not affect JAK1's stimulatory effect.

Animals↗

[Treatment of the deformed ear and jaw].

Lengthening of the mandible by gradual distraction and ear reconstruction using tissue expanders were performed on nine young patients (6-11 years old) with unilateral hemifacial microsomia. The technique holds promise for reconstruction of ear and mandible at the same time. This is essentially a pilot clinical project. A late follow-up of these patients is necessary.

Abnormalities, Multiple↗

A preliminary study on immune response to hepatitis E virus DNA vaccine in mice.

OBJECTIVE: In order to elicit immune response to hepatitis E virus (HEV) with the method of direct injection of naked DNA. METHODS: The gene encoding the structural protein of pORF3, a Chinese strain of HEV, was cloned into the eukaryotic expression plasmid pSVL. The resulted plasmid pSVL-HEV ORF3 was used as HEV DNA vaccine, to inoculate Balb/c mice intramuscularly with a dose of 100 micrograms. Mice injected with empty pSVL DNA served as control. RESULTS: After 1-2 times inoculation, twelve of 16 mice inoculated with pSVL-HEV ORF3 had anti-HEV IgG seroconversion. pSVL-HEV ORF3 was still detectable in the muscle of the inoculated mice 18 days after the injection, by the method of PCR. None of the control group had a detectable level of anti-HEV IgG. It is also found that the humoral immune response to HEV induced by DNA vaccine could be boostered by HEV recombinant fusion protein. CONCLUSION: Our present study demonstrated that nucleic acid vaccine is able to prime a specific humoral immune response to HEV in mice.

Animals↗

[Studies on peptide. XIX: Hepatitis C virus (HCV) immune selection].

HCV has characteristics of rapid variability. The amino terminus of E2/NS1 of HCV (amino acids sequence 384-414), which is hypervariable with respect to both nucleotide and amino acid sequence, has been termed the E2 HV domain or HVR1. The E2 HV domain appears to be a rapidly evolving region of the HCV genomes which may contain linear neutralizing epitopes and the E2 HV are under immune selection. For further studies of the immunogenicity on E2 HV of HCV, we selected three peptide fragments from the full length of E2 HV region sequence and synthesized them with SPPS method. The amino acid sequences are shown as following: P2: VDGDTHVTGGAQAKTTNR (381-398); P9: STHVTGAVQGHSIRGTTSLFTSGPAQKIQ (384-412); P10: RTYTSGGTAGHTTSGITSLFSPGASQKIQ (384-412). From the results of ELISA and anti-peptide Abs of rabbit sera, we conclude that there are anti-E2 HV Abs in immune host but they could not neutralize HCV, so these Abs were not reactive with all E2 HV epitopes that resulted in immune selection of escape mutants; the anti-E2 HV Abs, probably from the same genotype, contained some common structure in which E2 HV epitopes react with other anti-E2 HV Abs at 30%: the C-terminus of E2 HV region (398-412) caused the immune response to rabbits.

Amino Acid Sequence↗

[Establishment and application of reverse transcription-nested polymerase chain reaction for detection of hepatitis E RNA in serum].

A reverse transcription-nested polymerase chain reaction (RT-nPCR) for detection of hepatitis E virus (HEV) RNA in serum was established using two pairs of oligonucleotide acid from open reading frame 1 and 2 (ORF1 and ORF2) of HEV cDNA as the inner and outer primers. Eleven serial sera from two rhesus monkeys experimentally infected with HEV were tested for HEV RNA with established RT-nPCR. HEV RNA became detectable in these two monkeys on the sixth day and the ninth day, respectively, and persisted up to the 17th and the 22nd day after infection, respectively. Twenty-eight serum specimens of the 41 patients with acute sporadic hepatitis E were HEV RNA positive (68.3%). Proportions of positive HEV RNA in patients sera collected one to ten days, 11 to 20 days and 21 to 34 days after their onset of the disease were 72.7% (16/22), 70.0% (7/10) and 55.5% (5/9), respectively. It suggests that viremia of HEV lasts a shorter period, and proportion of serum positive HEV RNA decreases with the course of the disease.

Animals↗

[Transurethral noncontact laser ablation of the large prostate].

42 cases of the large benign hypertrophy of the prostate were treated by transurethral noncontact laser ablation. The results of the patients followed up no less than six months and treatment were reported. The technique of the procedure and its related problems were described and our experience was presented. If we use the technique of the procedure skill fully, noncontact laser ablation of large benign hypertrophy of the prostate is safe and effective.

Adolescent↗

[The surgical treatment for the epiglottic cancer extended to the base of tongue].

26 cases of the epiglottic cancer extended to the base of the tongue were studied retrospectively. Among them, 14 were male and 12 female. The age varied from 43 to 62. Besides two cases who underwent total laryngectomy, the other twenty-four were treated with supraglottic horizontal partial laryngectomy or horizontovertical subtotal laryngectomy and resection of part of base of the tongue. 11 cases received bilateral radical neck dissection (RND) and 10 cases unilateral RND simultenously. The results showed twenty-four cases had resumed speaking ability, twenty had been decannulated and restored the laryngeal functions. The 5-year survival rate was 57.9% (12/19). It was concluded that transpharyngeal approach was reasonable for supraglottic horizontal partial laryngectomy associated with the resection of the base of the tongue.

Adult↗

[Studies on synthetic peptide. XX: the antigenicity and linear epitope map of synthetic peptide hepatitis C virus].

Hepatitis C virus (HCV), the major causative agent of post transfusion non-A, non-B hepatitis (NANB), had been cloned and expressed. According to the protein sequence of HCV-BK and its epitope profiles which combined the hydrophilicity, accessibility, flexibility, antigenicity, charge distribution and HPLC reserve coefficient of protein using the "Goldkey" computer program, we designed and synthesized the following peptides: P1(475-495), P3(449-468), P4(658-663), P5(645-663), P6(484-489), P7(475-489), P15(655-662), P16(230-237), P17(225-237), P18(1220-1240), P19(1694-1735), P24(1230-1240), P25(1482-1493), P26(384-389), P27(2355-2389). The results of ELISA showed that P6(60% positive results) and P19(63% positive results) testing with PT-HC of Gu An, Hebei province were the major antigens in NS1 and in NS4 region, respectively.

Antigens, Viral↗

Transcriptional regulation of the apolipoprotein B-100 gene: identification of cis-acting elements in the first nontranslated exon of the human apolipoprotein B-100 gene.

Apolipoprotein B-100, produced primarily in the human liver, is the sole protein component of low-density lipoprotein and serves as a ligand for the LDL receptor. Two cis-acting positive elements between -128 and -70 control hepatic cell-specific expression of the human apoB gene (H. K. Das, T. Leff, and J. L. Breslow, J. Biol. Chem. 263: 11452-11458, 1988). In this study, two apoB cis-acting elements (+20 to +40; +43 to +53) have been identified using DNase I footprint analysis. Through in vitro mutagenesis and transient transfection experiments in Hep G2 and HeLa cells, the element (+20 to +40) was observed to have a negative effect on transcription of the apoB gene. The element (+43 to +53) was found to have a strong positive effect on apoB gene transcription in Hep G2 cells and mild positive effect in HeLa cells. Therefore these two cis-acting elements mediate hepatic-cell specific expression of the apolipoprotein gene by interacting with trans-acting protein factors.

Apolipoprotein B-100↗

Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2.

Apoptosis, or programmed cell death (PCD), recently has emerged as an important homeostatic mechanism within several hematopoietic lineages. This process is subject to both positive and negative modulation by cytokines and within the erythroid lineage is inhibited by interleukin-3, stem cell factor, and erythropoietin (Epo). Through the expression of carboxyl-truncated Epo receptor mutants in FDC-P1 cells, a receptor form possessing 80 membrane-proximal cytoplasmic residues is shown to efficiently mediate Epo-dependent inhibition of PCD. This is in contrast to previous studies that attributed this activity to a distal carboxyl-terminal receptor subdomain (and/or heterodimerization of wild type Epo receptors with a truncated non-functional receptor form). Epo-dependent inhibition of PCD also is shown to be blocked by ectopic expression of kinase-deficient dominant-negative forms of Jak2 (Jak2 delta VIII and Jak2-829), further underlining a role of this membrane-proximal subdomain of the Epo receptor in the inhibition of PCD. To our knowledge, this comprises the first direct evidence for an essential role for a Jak tyrosine kinase (Jak2) in this apoptotic response pathway.

Amino Acid Sequence↗

Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2-associated pathway.

Based on the recently implicated role of Shc as a signaling effector for type I cytokine receptors, factors which mediate the recruitment and phosphorylation of Shc in the erythropoietin receptor (EPOR) system have been studied. FDC-P1 cells stably expressing the wild type murine EPOR supported the EPO-induced association of Shc with Jak2 and its rapid tyrosine phosphorylation. However, this did not depend upon the presence of phosphotyrosine sites within the EPOR and was mediated by a mitogenically deficient receptor form (EPOR329) lacking cytoplasmic tyrosine residues. This was shown both by Western blotting of Shc and Jak2 co-immunoprecipitates and through the development of an in vitro assay for cytokine-induced Shc phosphorylation. The direct association of Shc with Jak2 also was observed and was shown to depend upon EPO-exposure and the SH2 subdomain of Shc. Together, these studies indicate that Jak2, in part, may mediate the EPO-induced phosphorylation of Shc.

Animals↗